Ferring Pharmaceuticals Inc. v. Fresenius Kabi USA, LLC
| FERRING PHARMACEUTICALS INC., FERRING INTERNATIONAL CENTER SA, FERRING B.V. and POLYPEPTIDE LABORATORIES A/S |
| FRESENIUS KABI USA, LLC |
| 23-1559 |
| March 7, 2023 |
| U.S. Court of Appeals, Federal Circuit |
| Patent - (ANDA) (Fed. Qst.) |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 9, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 3 Note to File: The following cases are consolidated: 23-1460 (Lead) with 23-1559 (Cross-Appeal). The parties must file all documents in the lead appeal only. [908986] [23-1460, 23-1559] [MMA] [Entered: 03/09/2023 04:50 PM] |
Filing 2
ORDER consolidating appeals (23-1460 and 23-1559). The revised official caption is reflected in the order. (See order for additional details). Service as of this date by the Clerk of Court. [908983] [23-1460, 23-1559] [MMA] [Entered: 03/09/2023 04:43 PM]
|
| Filing 1 Appeal docketed. Received: 02/24/2023. [908379] Entry of Appearance is due on 03/21/2023. Certificate of Interest is due on 03/21/2023. Docketing Statement is due on 03/21/2023. Appellant's brief is due on 05/08/2023. [CMH] [Entered: 03/07/2023 03:47 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
